There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

Traditional imaging techniques have struggled to capture these elusive cell populations and the sparse structures of bone marrow. As a result, there has been a growing need for a more precise ...

Patients mainly experience bone metastasis, which develops when the ... Diagnosis of any type of bone cancer typically ...

On World Cancer Day, we got in touch with an Orthopaedic Oncologist who shares the importance of early detection and expert ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. Laura is an assistant editor for The Scientist. She earned her ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

MRI liver imaging proved to be the most sensitive technique for detecting liver metastases. Bone scintigraphy and MRI revealed bone metastases equally well and were both superior to PET–CT.

Cancer metastasis—the spread of cancer to other organs—is the leading cause of death among cancer patients. Researchers have now uncovered a "genetic signature" of 177 genes shared across ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.